Patients Forum- II: “NEW DEVELOPMENTS IN MULTIPLE SCLEROSIS”(only in Spanish)
Wednesday, September 28th (11h00-12h30)
Room C
One of the most common central nervous system diseases (brain and spinal cord) is Multiple Sclerosis (MS). An estimated 47,000 people are affected in Spain, 600,000 in Europe and more than 2,000,000 in the world.
This disease of unknown cause, although the existence of a genetic predisposition is accepted, will be discussed with some of the most experienced stakeholders in the area.
Unmet needs, new developments in diagnosis and treatment, resources and services for patients and the economic impact will be priority topics of this session, as well as the present and future of research and communication in MS.
Moderator:
Pedro Carrascal: CEO, EM Spain, EM Euskadi, European Multiple Sclerosis Platform - EMSP (Spain)
Speakers:
Alfredo Rodríguez Antigüedad: Head of Neurology, BASURTO UNIVERSITY HOSPITAL (Spain)
Marta Príncep: CEO - GAEM & Technological Director - BELLAVISTA (Spain). “Do patients organizations
be effectively involved in research? The GAEM example”
Ángel Ayuga: Medical Manager Neurology & Immunology (N&I), MERCK SPAIN (Spain)
Arantxa Sancho López: Clinical Pharmacology, Institute of Investigation Puerta de Hierro of Madrid / CHMP Alternate Member, AEMPS - Spanish Agency for Medicines and Health Products (Spain)